Characterization of a human bispecific antibody against CD20/CD55 for the treatment of burkitt lymphoma

被引：0
|
作者：
Macor, Paolo [1 ]
Mezzaroba, Nelly [1 ]
De Maso, Luca [1 ]
Garrovo, Chiara [2 ]
Biffi, Stefania [2 ]
Sblattero, Daniele [3 ]
Marzari, Roberto [1 ]
Tedesco, Francesco [1 ]
机构：
[1] Univ Trieste, Dept Life Sci, Trieste, Italy
[2] CBM, Opt Imaging Lab, Trieste, Italy
[3] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy
来源：
IMMUNOBIOLOGY | 2012年 / 217卷 / 11期
关键词：
D O I：
10.1016/j.imbio.2012.08.060
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
59
引用
收藏
页码：1149 / 1150
页数：2
相关论文
共 50 条
  • [21] Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment
    Takuya Mizuno
    Yukinari Kato
    Mika K. Kaneko
    Yusuke Sakai
    Toshinori Shiga
    Masahiro Kato
    Toshihiro Tsukui
    Hirofumi Takemoto
    Akio Tokimasa
    Kenji Baba
    Yuki Nemoto
    Osamu Sakai
    Masaya Igase
    [J]. Scientific Reports, 10
  • [22] Production and Characterization of New Anti-Human CD20 Monoclonal Antibody
    Fasihi-Ramandi, Mahdi
    Amani, Jafar
    Salmanian, Ali-Hatef
    Moazzeni, Seyed Mohammad
    Ahmadi, Kazem
    [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2015, 14 (05) : 502 - 508
  • [23] Antibody against CD20 in patients with B cell malignancy
    Adamson, PJ
    Zola, H
    Nicholson, IC
    Pilkington, G
    Hohmann, A
    [J]. LEUKEMIA RESEARCH, 2001, 25 (12) : 1047 - 1050
  • [24] The susceptibility of freshly isolated B-non Hodgkin lymphoma cells to Rituximab and complement is determined by CD20 levels and the CD55/CD59 inhibitors.
    Golay, J
    Lazzari, M
    Facchinetti, V
    Borleri, G
    Dastoli, G
    Barbui, T
    Introna, M
    Rambaldi, A
    [J]. BLOOD, 2000, 96 (11) : 338A - 338A
  • [25] An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies
    Qi, Junpeng
    Chen, Shih-Shih
    Chiorazzi, Nicholas
    Rader, Christoph
    [J]. METHODS, 2019, 154 : 70 - 76
  • [26] CD20xCD3 Bispecific Fully Human Antibody Induces Potent Anti-Tumor Activity Against CD20-Expressing Tumors in Immune Competent Mice Humanized for CD20 and CD3
    Varghese, Bindu
    Menon, Jayanthi
    Rodriguez, Luis
    Olson, Kara
    Krueger, Pamela
    Huang, Tammy
    Smith, Eric
    Thurston, Gavin
    Kirshner, Jessica R.
    [J]. BLOOD, 2015, 126 (23)
  • [27] Recombinant bispecific monoclonal antibody (bsMAb) against CD20 and CD22 active in vitro and in vivo against B-cell lymphomas.
    Qu, Zhengxing
    Cardillo, Thomas M.
    Shi, Victoria
    Delaney, Diana L.
    Hansen, Hans J.
    Chang, Chien-Hsing
    Goldenberg, David M.
    [J]. BLOOD, 2006, 108 (11) : 713A - 714A
  • [28] Construction and Characterization of a Bispecific Anti-CD20 Antibody with Potent Antitumor Activity against B-Cell Lymphoma
    Li, Bohua
    Zhang, Xunming
    Shi, Shu
    Zhao, Lei
    Zhang, Dapeng
    Qian, Weizhu
    Zheng, Lei
    Gao, Jie
    Wang, Hao
    Guo, Yajun
    [J]. CANCER RESEARCH, 2010, 70 (15) : 6293 - 6302
  • [29] Pharmacodynamic Effects and Immune Correlates of Response to the CD20/CD3 Bispecific Antibody Mosunetuzumab in Relapsed or Refractory Non-Hodgkin Lymphoma
    Hernandez, Genevive
    Huw, Ling-Yuh
    Belousov, Anton
    Wilson, Deanna
    Koeppen, Hartmut
    McCord, Ron
    Peng, Kun
    Bartlett, Nancy L.
    Budde, Lihua E.
    Assouline, Sarit
    Nastoupil, Loretta J.
    Yoon, Dok Hyun
    Matasar, Matthew J.
    Bender, Brendan
    Kwan, Antonia
    Li, Chi-Chung
    O'Hear, Carol
    Yin, Shen
    Wei, Michael C.
    Adamkewicz, Joanne I.
    [J]. BLOOD, 2019, 134
  • [30] Development and Characterization of a New Antipeptide Monoclonal Antibody Directed to Human CD20 Antigen
    Habibi-Anbouhi, Mahdi
    Azadmanesh, Kayhan
    Behdani, Mahdi
    Hajizadeh-Saffar, Ensiyeh
    Vahabpour, Rouhollah
    Shokrgozar, Mohammad Ali
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2015, 30 (07) : 310 - 316
12345